DexCom DXCM delivered robust first-quarter 2025 results, underpinned by strong category demand, record new patient growth and ...

Severe adverse events, including seizure and loss of consciousness, were potentially linked to the issue, based on 56 reports ...

The American Diabetes Association’s annual conference kicks off amid a dynamic year for diabetes tech, as access improves for ...

Dexcom is working to replace some of the receivers that link with its continuous glucose monitoring systems due to a ...

I paired my Oura ring with Dexcom's Stelo CGM to track my glucose. Here's what I learned about my eating habits.

The FDA has recalled 2 million Dexcom glucose monitors due to a serious safety risk. Learn how diabetic patients should act ...

DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and ...

The FDA's recall database today posted notices related to a Class I recall for continuous glucose monitor components made by ...

The evolution of diabetes technologies has led to the expansion of automated insulin delivery for type 2 diabetes, continuous ...

Looking back on patient monitoring stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including DexCom ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $98.38, a high estimate of $106.00, and a low estimate of $85.00. Surpassing the previous average price ...

Use of real-time continuous glucose monitoring did not improve perinatal outcomes among women with gestational diabetes, ...